Gibbons's team51 used BAPN drugs to inhibit LOX enzyme activity, and transwell migration and collagen invasion assays found that lung cancer cell migration was inhibited in vitro, while in mice vivo experiments did not show significant change in tumor size. The gene discussed is LOX; the disease is lung carcinoma.